000 | 01916 a2200565 4500 | ||
---|---|---|---|
005 | 20250517161230.0 | ||
264 | 0 | _c20170925 | |
008 | 201709s 0 0 eng d | ||
022 | _a1528-0020 | ||
024 | 7 |
_a10.1182/blood-2016-11-752840 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMachlus, Kellie R | |
245 | 0 | 0 |
_aSelinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis. _h[electronic resource] |
260 |
_bBlood _c08 2017 |
||
300 |
_a1132-1143 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase I; Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 |
_aBone Marrow _xdrug effects |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aFetus _xpathology |
650 | 0 | 4 |
_aHydrazines _xadverse effects |
650 | 0 | 4 |
_aLiver _xembryology |
650 | 0 | 4 |
_aMegakaryocytes _xdrug effects |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aStem Cells _xcytology |
650 | 0 | 4 |
_aThrombocytopenia _xblood |
650 | 0 | 4 |
_aThrombopoiesis _xdrug effects |
650 | 0 | 4 |
_aThrombopoietin _xmetabolism |
650 | 0 | 4 |
_aTriazoles _xadverse effects |
700 | 1 | _aWu, Stephen K | |
700 | 1 | _aVijey, Prakrith | |
700 | 1 | _aSoussou, Thomas S | |
700 | 1 | _aLiu, Zhi-Jian | |
700 | 1 | _aShacham, Eran | |
700 | 1 | _aUnger, T J | |
700 | 1 | _aKashyap, Trinayan | |
700 | 1 | _aKlebanov, Boris | |
700 | 1 | _aSola-Visner, Martha | |
700 | 1 | _aCrochiere, Marsha | |
700 | 1 | _aItaliano, Joseph E | |
700 | 1 | _aLandesman, Yosef | |
773 | 0 |
_tBlood _gvol. 130 _gno. 9 _gp. 1132-1143 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2016-11-752840 _zAvailable from publisher's website |
999 |
_c27292633 _d27292633 |